A. Redeker

发表

Twenty isoniazid-associated deaths in one state.

G. Kanel, T. Moulding, A. Redeker, 1989, The American review of respiratory disease.

Spontaneous decrease in portal pressure with clinical improvement in cirrhosis.

T. Reynolds, A. Redeker, H. M. Geller, 1960, The New England journal of medicine.

Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial.

T. Reynolds, A. Redeker, M. Olivier, 1973 .

Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti‐HCV reactive patients with normal liver tests

S. Govindarajan, T. Fong, B. Valinluck, 1996, Journal of medical virology.

Natural course of delta superinfection in chronic hepatitis B virus‐infected patients: Histopathologic study with multiple liver biopsies

K. D. de Cock, S. Govindarajan, A. Redeker, 1986, Hepatology.

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

S. Hadler, J. Miller, D. Ostrow, 1982, Annals of internal medicine.

Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis.

M. Houghton, Q. Choo, J. McHutchison, 1991, Gastroenterology.

Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding.

F. Villamil, T. Reynolds, T. Morgan, 1986, Gastroenterology.

Fulminant hepatitis A in intravenous drug users with chronic liver disease.

A. Redeker, E. Akriviadis, E. Akriviadis, 1989, Annals of internal medicine.

Analysis of cardioportal circulation time by means of simultaneous direct hepatic venous counting.

I. Mena, T. Reynolds, A. Redeker, 1960, The New England journal of medicine.

Hepatic wedge pressure, blood flow, vascular resistance and oxygen consumption in cirrhosis before and after end-to-side portacaval shunt.

T. Reynolds, A. Redeker, H. Geller, 1958, The Journal of clinical investigation.

Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

A. Redeker, H. Yamahiro, 1973, Lancet.

The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A

A. Redeker, M. Ashcavai, H. Kao, 1984, Hepatology.

Delta agent and hepatitis B.

A. Redeker, 1983, Annals of internal medicine.

Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure.

T. Reynolds, T. Boyer, D. Triger, 1977, Gastroenterology.

Fulminant hepatic and renal failure complicating Wilson's disease.

G. Kanel, T. Reynolds, T. Uchida, 2008, Liver.

Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency.

R. Peters, T. Starzl, A. Redeker, 1980, The New England journal of medicine.

A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta

M. Houghton, A. Weiner, Q. Choo, 1988, Journal of virology.

Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit

T. Reynolds, K. Hu, A. Redeker, 2000, American Journal of Gastroenterology.

Liver replacement for alpha1-antitrypsin deficiency.

T. Starzl, C. Putnam, R. Peters, 1977, Surgery.

Hepatitis B surface antigen in pancreatic and biliary secretions

J. Hoefs, A. Redeker, M. Ashcavai, 1980 .

Percutaneous transhepatic cholangiography. An improved technique.

G. Karvountzis, A. Redeker, M. Horisawa, 1975, JAMA.

A controlled study of the effects of L-arginine on hepatic encephalopathy.

T. Reynolds, A. Redeker, P. Davis, 1958, The American journal of medicine.

Hepatitis B virus infection in dentists.

J. Mosley, E. White, A. Redeker, 1975, The New England journal of medicine.

Acute hepatitis induced by bupropion.

G. Kanel, K. Hu, A. Redeker, 2000, Digestive diseases and sciences.

Serologic characterization of patients with two episodes of acute viral hepatitis.

G. Karvountzis, J. Mosley, A. Redeker, 1975, The American journal of medicine.

Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis.

J. Mosley, D. Gocke, A. Redeker, 1975, The New England journal of medicine.

Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.

M. Omata, T. Reynolds, T. Boyer, 1980, Gastroenterology.

Improved detection of hepatitis c virus antibodies in high‐risk populations

S. Govindarajan, J. McHutchison, G. Kuo, 1992, Hepatology.

Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices.

A. J. Donovan, T. Reynolds, W. Mikkelsen, 1981, Gastroenterology.

Functional renal failure with cirrhosis. The effect of plasma expansion therapy.

T. Reynolds, A. Redeker, F. Lieberman, 1967, Medicine.

Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis.

G. Kanel, E. Kaptein, T. Reynolds, 1982, Gastroenterology.

Hemolytic anemia in wilson disease: Clinical findings and biochemical mechanisms

S. Forman, P. Hochstein, A. Redeker, 1980, American journal of hematology.

Long Term Follow-Up Studies of Patients Surviving Fulminant Viral Hepatitis

G. Karvountzis, R. Peters, A. Redeker, 1974 .

A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection.

G. Vyas, J. Weiner, M. Tong, 1979, The Journal of infectious diseases.

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

M. Mizokami, T. Morgan, N. Tsai, 1998, Journal of hepatology.

Wedged hepatic venous pressure; a clinical evaluation.

T. Reynolds, A. Redeker, H. Geller, 1957, The American journal of medicine.

Hepatitis a virus infection in fulminant hepatitis and chronic active hepatitis

J. Rakela, R. Decker, J. Mosley, 1978 .

An effective treatment of refractory ascites in cirrhosis of the liver.

T. Reynolds, A. Redeker, O. Kuzma, 1960, Archives of internal medicine.

Appraisal of the mortality in acute fulminant viral hepatitis.

M. A. Davis, R. Peters, T. Reynolds, 1968, The New England journal of medicine.

A Controlled Study of the Safety of Pooled Plasma Stored in the Liquid State at 30–32 C for Six Months

C. Hopkins, A. Redeker, B. Jackson, 1968, Transfusion.

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Jules L. Dienstag, M. Alter, R. Purcell, 1989 .

Multiple Hepatitis Viruses in Multiple Attacks of Acute Viral Hepatitis

R. Purcell, J. Mosley, S. Feinstone, 1977 .

Viral hepatitis: clinical aspects.

A. Redeker, 1975, The American journal of the medical sciences.

Etiology of sporadic hepatitis B surface antigen-negative hepatitis.

R. Purcell, J. Dienstag, J. Mosley, 1977, Annals of internal medicine.

Indirect reacting hyperbilirubinemia in cirrhosis: Its relation to red cell survival

T. Reynolds, A. Redeker, B. Felsher, 1968, The American Journal of Digestive Diseases.

Viral hepatitis: current concepts.

A. Redeker, 1973, Postgraduate medicine.

Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis.

G. Karvountzis, A. Redeker, 1974, Annals of internal medicine.

Chronic liver disease after acute non-A, non-B viral hepatitis.

J. Rakela, A. Redeker, 1979, Gastroenterology.

Successful renal transplantation in patients positive for hepatitis B antigen.

T. Berne, A. Redeker, S. Chatterjee, 1974, The New England journal of medicine.

Prevalence of Septic Events, Type 1 Hepatorenal Syndrome, and Mortality in Severe Alcoholic Hepatitis and Utility of Discriminant Function and MELD Score in Predicting These Adverse Events

S. Verma, A. Redeker, M. Mendler, 2006, Digestive Diseases and Sciences.

Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy

M. Omata, T. Reynolds, T. Boyer, 1980 .

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

F. Villamil, J. Vierling, T. Fong, 1999 .

Host dependent modulation of hepatitis delta virus replication in chronic delta hepatitis

Sanjeev Gupta, S. Govindarajan, B. Valinluck, 1991, Journal of medical virology.

Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.

J. Rakela, A. Redeker, B. Weliky, 1983, Gastroenterology.

Delayed HBsAg clearance in chronic hepatitis B viral infection

K. Lindsay, A. Redeker, M. Ashcavai, 1981, Hepatology.

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

H J Alter, C E Stevens, R H Purcell, 1990, Science.

Treatment of fulminant hepatic failure with insulin and glucagon

G. Woolf, A. Redeker, 2005, Digestive Diseases and Sciences.

HBsAg clearance in chronic active hepatitis B

A. Redeker, M. Ashcavai, Suyenori Yamada, 1986, Digestive Diseases and Sciences.

Hepatitis B surface antigen in pancreatic and biliary secretions.

J. Hoefs, A. Redeker, I. Renner, 1980, Gastroenterology.

POSSIBLE CASE OF HBV-2 INFECTION

S. Govindarajan, A. Redeker, 1988, The Lancet.

Spontaneous Reactivation in Chronic Hepatitis B: Patterns and Natural History

Sanjeev Gupta, S. Govindarajan, T. Fong, 1990, Journal of clinical gastroenterology.

More Advanced Hepatic Fibrosis in Hispanics with Chronic Hepatitis C Infection: Role of Patient Demographics, Hepatic Necroinflammation, and Steatosis

G. Kanel, S. Verma, S. Govindarajan, 2006, The American Journal of Gastroenterology.

Correlation of IgM anti‐hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV

Sanjeev Gupta, S. Govindarajan, B. Valinluck, 1989, Hepatology.

Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection

S. Govindarajan, A. Redeker, K. Chin, 1988, Digestive Diseases and Sciences.

Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: The role of hepatitis B, C or D?

Z. Ackerman, S. Govindarajan, J. McHutchison, 1992, Hepatology.

Short-term prednisone in chronic hepatitis B

J. Rakela, A. Redeker, 1984 .

Prognostic implications of the e antigen of hepatitis B virus.

J. Mosley, A. Redeker, V. Edwards, 1977, JAMA.

Hepatitis B. Risk of infection from antigen-positive medical personnel and patients.

A. Redeker, 1975, JAMA.

Specialty conference: Chronic hepatitis B.

R. Peters, T. Reynolds, M. Tong, 1978, The Western journal of medicine.

Viral, host and interferon‐related factors modulating the effect of interferon therapy for hepatitis C virus infection

J. Vierling, K. Hu, A. Redeker, 2001, Journal of viral hepatitis.

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C

M. Mizokami, T. Morgan, N. Tsai, 1998 .

Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy

S. Verma, A. Redeker, M. Mendler, 2004, American Journal of Gastroenterology.

Subdeterminants d and y of hepatitis B antigen as epidemiologic markers.

J. Mosley, A. Redeker, V. Edwards, 1972, American journal of epidemiology.

Distribution of hepatitis B antigenic determinants in different forms of viral hepatitis.

M. Berberian, A. Redeker, I. Gordon, 1972, The Journal of infectious diseases.

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis

F. Villamil, J. Vierling, T. Fong, 1999, American Journal of Gastroenterology.

Status of hepatitis B virus DNA in alcoholic liver disease: A study of a large urban population in the United States

S. Govindarajan, T. Fong, B. Valinluck, 1988, Hepatology.

Spontaneous rupture of nonparasitic cyst of the liver.

P. Ralls, A. Redeker, E. Akriviadis, 1989, Gastroenterology.

Extra- and Intrahepatic Portal Hypertension without Cirrhosis (Hepatoportal Sclerosis)

T. Reynolds, A. Redeker, R. L. Peters, 1965, Annals of surgery.

Intrahepatic HCV levels in chronic HCV infection

M. Bonacini, A. Redeker, 1999, Gut.

Report of a WHO Scientific Group (Part 1 of 2)

J. H. Wells, M. Devey, E. Holborow, 1972 .

Splenic hemorrhage following percutaneous splenoportography.

T. Reynolds, W. Mikkelsen, A. Redeker, 1955, Journal of the American Medical Association.

Bile duct stricture shown during transhepatic cholangiography by use of cholecystokinin.

H. Juttner, A. Redeker, C. Smith, 1981, The Western journal of medicine.

Urine and serum zinc abnormalities in disease of the liver.

T. Reynolds, A. Redeker, H. Helwig, 1965, American journal of clinical pathology.

Jaundice associated with chlorpromazine (thorazine) therapy.

D. Balfour, A. Redeker, 1955, Gastroenterology.

Long term follow-up studies of patients surviving fluminant viral hepatitis.

G. Karvountzis, A. Redeker, R. L. Peters, 1974, Gastroenterology.

CASE REPORT: Acute Hepatitis Induced by Bupropion

G. Kanel, K. Hu, A. Redeker, 2000, Digestive Diseases and Sciences.

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen.

T. Starzl, C. Putnam, S. Iwatsuki, 1979, Archives of surgery.

[Results of a glaucoma mass screening program (author's transl)].

A. Redeker, U. Loewen, B. Handrup, 1976, Klinische Monatsblatter fur Augenheilkunde.

Acetaminophen, isoniazid, and hepatic toxicity.

G. Kanel, T. Moulding, A. Redeker, 1991, Annals of internal medicine.

Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States

Ying-Chao Lin, Huiying Yang, K. Lindsay, 2004, International journal of medical sciences.

Clinical comparison of end-to-side and side-to-side portacaval shunt.

T. Reynolds, W. Mikkelsen, F. Turrill, 1966, The New England journal of medicine.

Chapter 27 – Hepatic Hemodynamics and Portal Hypertension

T. Reynolds, A. Redeker, 1965 .

Detection of antibody to hepatitis-associated antigen by indirect counterimmunoelectrophoresis.

D. Gocke, A. Redeker, D. Tripodi, 1973, American Journal of Clinical Pathology.

The prevention of hepatitis B by vaccine.

S. Hadler, Jeffrey H. Miller, D. Ostrow, 2020, Dental update.

A comparative clinical evaluation of hepatitis-associated antigen detection.

A. Redeker, D. Tripodi, W. Pollack, 1972, International Archives of Allergy and Applied Immunology.

Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, andE. coli antibodies

A. Waxman, T. Reynolds, T. Boyer, 1979, Digestive Diseases and Sciences.

SEROLOGICAL RESPONSE TO HEPATITIS DELTA VIRUS IN HEPATITIS D

S. Govindarajan, K. Decock, A. Redeker, 1987, The Lancet.

Hepatitis B: risk of infection from antigen-positive medical personnel and patients.

A. Redeker, 1975, Anesthesia Progress.

In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow‐up associated with a poorer outcome?

S. Verma, A. Redeker, 2005, Hepatology.

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

B. Moss, J. Sidney, A. Sette, 1995, The Journal of experimental medicine.

Oxyphenisatin and jaundice.

T. Reynolds, A. Redeker, 1970, JAMA.

Prevalence of hepatitis G virus among intravenous drug abusers in Los Angeles.

S. Geller, R. Botla, T. Fong, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatocellular carcinoma in a case of Wilson's disease.

S. Govindarajan, A. Redeker, A. Redeker, 2008, Liver.

Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States

Ying-Chao Lin, K. Lindsay, K. Hu, 2004, International journal of medical sciences.

Treatment of chronic active hepatitis. Good news and bad news.

A. Redeker, 1981, New England Journal of Medicine.

Clinical Comparison of the End‐to-Side and Side‐to-Side Portacaval Shunt: Ten Year Follow‐up

T. Reynolds, S. Iwatsuki, W. Mikkelsen, 1973, Annals of Surgery.

Delta hepatitis in the Los Angeles area: a report of 126 cases.

K. D. de Cock, S. Govindarajan, A. Redeker, 1986, Annals of internal medicine.

A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis.

T. Fong, J. Person, A. Redeker, 1993, Journal of clinical gastroenterology.